Favorable effects of vildagliptin on metabolic and cognitive dysfunctions in streptozotocin-induced diabetic rats

European Journal of Pharmacology

Volumn 769, Issue , 2015, Pages 297-305

  El Batsh, Maha M ^a   El Batch, Manal M ^b   Shafik, Noha M ^b   Younos, Ibrahim H ^c  

^a MENOUFIA UNIVERSITY   (Egypt)

^b TANTA UNIVERSITY   (Egypt)

^c SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Cognition; Diabetes mellitus; Dipeptidyl peptidase IV; Streptozotocin; Vildagliptin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DIPEPTIDYL PEPTIDASE IV; GLUCOSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; VILDAGLIPTIN; ADAMANTANE; NEUROPROTECTIVE AGENT; NITRILE; PYRROLIDINE DERIVATIVE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD SAMPLING; COGNITION ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; DPP IV GENE; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; INSULIN BLOOD LEVEL; LEARNING DISORDER; LIPID BLOOD LEVEL; MALE; MDA GENE; MEMORY DISORDER; MENTAL TASK; NFKAPPAB GENE; NONHUMAN; OXIDATIVE STRESS; P65 GENE; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TNF ALPHA GENE; TREATMENT OUTCOME; WEIGHT GAIN; ANALOGS AND DERIVATIVES; ANIMAL; ANIMAL BEHAVIOR; BODY WEIGHT; BRAIN; COGNITION; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ADAMANTANE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; COGNITION; DIABETES MELLITUS, EXPERIMENTAL; MALE; NEUROPROTECTIVE AGENTS; NITRILES; OXIDATIVE STRESS; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84949035544     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2015.11.033     Document Type: Article

References (60)

1. T. Abbas, E. Faivre, and C. Holscher Impairment of synaptic plasticity and memory formation in GLP-1 receptor KO mice: interaction between type 2 diabetes and Alzheimer's disease Behav. Brain Res. 205 2009 265 271
2. D. Ahmed, V. Kumar, A. Verma, P.S. Gupta, H. Kumar, V. Dhingra, V. Mishra, and M. Sharma Antidiabetic, renal/hepatic/pancreas/cardiac protective and antioxidant potential of methanol/dichloromethane extract of Albizzia Lebbeck Benth. stem bark (ALEx) on streptozotocin induced diabetic rats BMC Complement. Altern. Med. 14 2014 243
3. B. Ahren, A. Schweizer, S. Dejager, E.B. Villhauer, B.E. Dunning, and J.E. Foley Mechanisms of action of the dipeptidyl peptidase-4 inhibitor vildagliptin in humans Diabetes Obes. Metab. 13 2011 775 783
4. Z. Arvanitakis, R.S. Wilson, J.L. Bienias, D.A. Evans, and D.A. Bennett Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function Arch. Neurol. 61 2004 661 666
5. D.L. Avila, G.R. Araujo, M. Silva, P.H. Miranda, M.F. Diniz, M.L. Pedrosa, M.E. Silva, W.G. de Lima, and D.C. Costa Vildagliptin ameliorates oxidative stress and pancreatic beta cell destruction in type 1 diabetic rats Arch. Med. Res. 44 2013 194 202
6. N. Aytan, T. Jung, F. Tamturk, T. Grune, and N. Kartal-Ozer Oxidative stress related changes in the brain of hypercholesterolemic rabbits Biofactors 33 2008 225 236
7. L.L. Baggio, and D.J. Drucker Biology of incretins: GLP-1 and GIP Gastroenterology 132 2007 2131 2157
8. G.J. Biessels, M.W. Strachan, F.L. Visseren, L.J. Kappelle, and R.A. Whitmer Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol. 2 2014 246 255
9. L. Bouwens, and I. Rooman Regulation of pancreatic beta-cell mass Physiol. Rev. 85 2005 1255 1270
10. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal. Biochem. 72 1976 248 254
11. E. Bruel-Jungerman, S. Laroche, and C. Rampon New neurons in the dentate gyrus are involved in the expression of enhanced long-term memory following environmental enrichment Eur. J. Neurosci. 21 2005 513 521
12. L.B. Ceretta, G.Z. Reus, H.M. Abelaira, K.F. Ribeiro, G. Zappellini, F.F. Felisbino, A.V. Steckert, F. Dal-Pizzol, and J. Quevedo Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats Exp. Diabetes Res. 2012 2012 302682
13. S. Chen, A.R. Liu, F.M. An, W.B. Yao, and X.D. Gao Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4 Age 34 2012 1211 1224
14. S. Craft, and G.S. Watson Insulin and neurodegenerative disease: shared and specific mechanisms Lancet Neurol. 3 2004 169 178
15. Miranda P.H. de Amorim, O.M. Monteiro, J.V. Rossoni Jr, M.E. Silva, Lima de, W.G. Daniela, C., and D.C. Costa Vildagliptin induces β-Cell neogenesis and improves the lipid profile in a later phase of type 1 diabetes Curr. Pharm. Biotechnol. 16 2015 60 65
16. S.L. Dix, and J.P. Aggleton Extending the spontaneous preference test of recognition: evidence of object-location and object-context recognition Behav. Brain Res. 99 1999 191 200
17. A. Etemad, F. Sheikhzadeh, and N.A. Asl Evaluation of brain-derived neurotrophic factor in diabetic rats Neurol. Res. 37 2015 217 222
18. M.S. Hayden, and S. Ghosh Signaling to NF-kappaB Genes Dev. 18 2004 2195 2224
19. M. Hino, H. Fuyamada, T. Hayakawa, T. Nagatsu, and H. Oya X-Prolyl dipeptidyl-aminopeptidase activity, with X-proline p-nitroanilides as substrates, in normal and pathological human sera Clin. Chem. 22 1976 1256 1261
20. G. Hughes, M.P. Murphy, and E.C. Ledgerwood Mitochondrial reactive oxygen species regulate the temporal activation of nuclear factor kappaB to modulate tumour necrosis factor-induced apoptosis: evidence from mitochondria-targeted antioxidants Biochem. J. 389 2005 83 89
21. P.M. Kidd Omega-3 DHA and EPA for cognition, behavior, and mood: clinical findings and structural-functional synergies with cell membrane phospholipids Altern. Med. Rev. 12 2007 207 227
22. S. Kim, I. Millet, H.S. Kim, J.Y. Kim, M.S. Han, M.K. Lee, K.W. Kim, R.S. Sherwin, M. Karin, and M.S. Lee NF-kappa B prevents beta cell death and autoimmune diabetes in NOD mice Proc. Natl. Acad. Sci. USA 104 2007 1913 1918
23. S.E. Kim, I.G. Ko, B.K. Kim, M.S. Shin, S. Cho, C.J. Kim, S.H. Kim, S.S. Baek, E.K. Lee, and Y.S. Jee Treadmill exercise prevents aging-induced failure of memory through an increase in neurogenesis and suppression of apoptosis in rat hippocampus Exp. Gerontol. 45 2010 357 365
24. C.T. Kodl, and E.R. Seaquist Cognitive dysfunction and diabetes mellitus Endocr. Rev. 29 2008 494 511
25. Y. Kono Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase Arch. Biochem. Biophys. 186 1978 189 195
26. A. Kuhad, M. Bishnoi, V. Tiwari, and K. Chopra Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits Pharmacol. Biochem. Behav. 92 2009 251 259
27. A. Kuhad, and K. Chopra Curcumin attenuates diabetic encephalopathy in rats: behavioral and biochemical evidences Eur. J. Pharmacol. 576 2007 34 42
28. A. Kuhad, and K. Chopra Lycopene ameliorates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rat Indian J. Exp. Biol. 46 2008 108 111
29. A. Kuhad, R. Sethi, and K. Chopra Lycopene attenuates diabetes-associated cognitive decline in rats Life Sci. 83 2008 128 134
30. A.M. Lambeir, C. Durinx, S. Scharpe, and M.I. De Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV Crit. Rev. Clin. Lab. Sci. 40 2003 209 294
31. Y. Li, T. Hansotia, B. Yusta, F. Ris, P.A. Halban, and D.J. Drucker Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis J. Biol. Chem. 278 2003 471 478
32. Zh Liu, Xr Zhang, Xy Hu, My Cheng, Jy Xu, and Yc Du Effect of glucocorticoid on MIP-1 and NF-B expressing in the lung of rats undergoing mechanical ventilation with a high tidal volume World J. Emerg. Med. 2 2011 66 69
33. S. Maeda, T. Matsui, and S. Yamagishi Vildagliptin inhibits oxidative stress and vascular damage in streptozotocin-induced diabetic rats Int. J. Cardiol. 158 2012 171 173
34. P. Martin-Gallan, A. Carrascosa, M. Gussinye, and C. Dominguez Oxidative stress in childhood type 1 diabetes: results from a study covering the first 20 years of evolution Free Radic. Res. 41 2007 919 928
35. N. Matikainen, S. Manttari, A. Schweizer, A. Ulvestad, D. Mills, B.E. Dunning, J.E. Foley, and M.R. Taskinen Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes Diabetologia 49 2006 2049 2057
36. A.V. Matveyenko, J.D. Veldhuis, and P.C. Butler Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein Am. J. Physiol. Endocrinol. Metab. 295 2008 E569 E574
37. J. Mu, J. Woods, Y.P. Zhou, R.S. Roy, Z. Li, E. Zycband, Y. Feng, L. Zhu, C. Li, A.D. Howard, D.E. Moller, N.A. Thornberry, and B.B. Zhang Chronic inhibition of dipeptidyl peptidase-4 with a sitagliptin analog preserves pancreatic β-cell mass and function in a rodent model of type 2 diabetes Diabetes 55 2006 1695 1704
38. M. Muriach, M. Flores-Bellver, F.J. Romero, and J.M. Barcia Diabetes and the brain: oxidative stress, inflammation, and autophagy Oxidative Med. Cell. Longev. 2014 2014 102158
39. T.J. Nelson, and D.L. Alkon Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration Biochem. Soc. Trans. 33 2005 1033 1036
40. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
41. M.S. Ola, A.M. Aleisa, S.S. Al-Rejaie, H.M. Abuohashish, M.Y. Parmar, A.S. Alhomida, and M.M. Ahmed Flavonoid, morin inhibits oxidative stress, inflammation and enhances neurotrophic support in the brain of streptozotocin-induced diabetic rats Neurol. Sci. 35 2014 1003 1008
42. K.L. Paumier, C.E. Sortwell, L. Madhavan, B. Terpstra, B.F. Daley, and T.J. Collier Tricyclic antidepressant treatment evokes regional changes in neurotrophic factors over time within the intact and degenerating nigrostriatal system Exp. Neurol. 266 2015 11 21
43. D.C. Perantie, A. Lim, J. Wu, P. Weaver, S.L. Warren, M. Sadler, N.H. White, and T. Hershey Effects of prior hypoglycemia and hyperglycemia on cognition in children with type 1 diabetes mellitus Pediatr. Diabetes 9 2008 87 95
44. H. Pintana, N. Apaijai, N. Chattipakorn, and S.C. Chattipakorn DPP-4 inhibitors improve cognition and brain mitochondrial function of insulin-resistant rats J. Endocrinol. 218 2013 1 11
45. N. Pipatpiboon, H. Pintana, W. Pratchayasakul, N. Chattipakorn, and S.C. Chattipakorn DPP4-inhibitor improves neuronal insulin receptor function, brain mitochondrial function and cognitive function in rats with insulin resistance induced by high-fat diet consumption Eur. J. Neurosci. 37 2013 839 849
46. B. Richter, E. Bandeira-Echtler, K. Bergerhoff, and C.L. Lerch Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus Cochrane Database Syst. Rev. 2008 CD006739
47. M.R. Rizzo, M. Barbieri, R. Marfella, and G. Paolisso Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes: role of dipeptidyl peptidase-IV inhibition Diabetes Care 35 2012 2076 2082
48. Y. Sato, S. Koshioka, Y. Kirino, T. Kamimoto, K. Kawazoe, S. Abe, K. Minakuchi, and Y. Nakahori Role of dipeptidyl peptidase IV (DPP4) in the development of dyslipidemia: DPP4 contributes to the steroid metabolism pathway Life Sci. 88 2011 43 49
49. J. Satoh, S. Yagihashi, and T. Toyota The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy Exp. Diabesity Res. 4 2003 65 71
50. N. Schroder, S.J. O'Dell, and J.F. Marshall Neurotoxic methamphetamine regimen severely impairs recognition memory in rats Synapse 49 2003 89 96
51. A.K. Singh Dipeptidyl peptidase-4 inhibitors: novel mechanism of actions Indian J. Endocrinol. Metab. 18 2014 753 759
52. S. Srodulski, S. Sharma, A.B. Bachstetter, J.M. Brelsfoard, C. Pascual, X.S. Xie, K.E. Saatman, L.J. Van Eldik, and F. Despa Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin Mol. Neurodegener. 9 2014 30
53. M. Tuzcu, and G. Baydas Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats Eur. J. Pharmacol. 537 2006 106 110
54. S. Vaughan, and P.S. Jat Deciphering the role of nuclear factor-kappaB in cellular senescence Aging (Albany N.Y.) 3 2011 913 919
55. A. Vella, G. Bock, P.D. Giesler, D.B. Burton, D.B. Serra, M.L. Saylan, B.E. Dunning, J.E. Foley, R.A. Rizza, and M. Camilleri Effects of dipeptidyl peptidase-4 inhibition on gastrointestinal function, meal appearance, and glucose metabolism in type 2 diabetes Diabetes 56 2007 1475 1480
56. V.Y. Waisundara, A. Hsu, B.K. Tan, and D. Huang Baicalin improves antioxidant status of streptozotocin-induced diabetic Wistar rats J. Agric. Food Chem. 57 2009 4096 4102
57. M. Wojdemann, A. Wettergren, B. Sternby, J.J. Holst, S. Larsen, J.F. Rehfeld, and O. Olsen Inhibition of human gastric lipase secretion by glucagon-like peptide-1 Dig. Dis. Sci. 43 1998 799 805
58. Y. Yang, Y. Wu, S. Zhang, and W. Song High glucose promotes Abeta production by inhibiting APP degradation PLoS One 8 2013 e69824
59. W.Q. Zhao, H. Chen, M.J. Quon, and D.L. Alkon Insulin and the insulin receptor in experimental models of learning and memory Eur. J. Pharmacol. 490 2004 71 81
60. D.B. Zorov, M. Juhaszova, and S.J. Sollott Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release Physiol. Rev. 94 2014 909 950